| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Transforming growth factor beta-2;TGF-beta-2;Latency-associated peptide;LAP;Tgfb2; |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Expression System | |
| Gene ID | |
| Immunogen | Expression system for standard: NS0; Immunogen sequence: A303-S414 |
| Product Type | |
| Reactivity | |
| Sample Type(s) | cell culture supernatants, serum and plasma (heparin, EDTA, citrate). |
| Sensitivity | |
| Storage | |
| Target | |
| UniProt # |
Background
Also known as: Transforming growth factor beta-2, TGF-beta-2, Latency-associated peptide, LAP, Tgfb2.
Mouse TGF-Beta 2 (TGFB2) is an established target in many assay panels, supporting hypothesis testing across diverse biological systems. This target is frequently investigated in Molecular & Cellular Biology research contexts. Growth factors and morphogens regulate cell proliferation, differentiation, survival, and tissue remodeling by engaging surface receptors and activating downstream signaling cascades. Their activity is often context-dependent, shaped by receptor availability, extracellular matrix binding, and feedback regulation.
Biological function and mechanism
In many systems, growth-factor signaling integrates environmental cues with developmental or repair programs. Downstream pathways frequently include kinase signaling modules and transcriptional responses that alter cell-cycle control, migration, or lineage specification. Because these signals can be transient, quantitative measurements are useful for understanding timing and dose dependence.
Why it matters in research
- Pathway engagement: Concentration changes can indicate activation of growth, survival, or differentiation programs.
- Tissue remodeling: Levels may relate to repair, fibrosis, angiogenesis, or developmental patterning in model systems.
- Mechanistic studies: Tracking abundance alongside downstream markers helps connect ligand availability to signaling output.
Disease and translational relevance
Altered growth-factor signaling has been reported across diverse conditions, including cancer biology, cardiovascular remodeling, wound repair, and metabolic dysfunction. For research interpretation, consider whether the measured form represents active ligand, bound complexes, or processed fragments, as these can influence apparent levels.
Sample data
| Concentration (pg/ml) | 0 | 31.2 | 62.5 | 125 | 250 | 500 | 1000 | 2000 |
| O.D. | 0.0 | 0.018 | 0.036 | 0.082 | 0.182 | 0.449 | 1.05 | 2.29 |
Intra/inter assay consistency
| Intra-Assay Precision | Inter-Assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 16 | 16 | 16 | 24 | 24 | 24 |
| Mean (pg/ml) | 98 | 235 | 827 | 102 | 215 | 805 |
| Standard deviation | 6.46 | 11.98 | 54.58 | 7.54 | 11.82 | 64.4 |
| CV (%) | 6.6% | 8% | 6.6% | 7.4% | 5.5% | 8% |
Kit components
Description|Quantity Pre-coated 96-well strip microplate|1 Standard|2 vials Biotinylated antibody (100x)|100ul Avidin-Biotin-Peroxidase Complex (100x)|100ul Sample Diluent|30ml Antibody Diluent|12ml Avidin-Biotin-Peroxidase Diluent|12ml Color Developing Reagent (TMB)|10ml Stop Solution|10ml Wash Buffer (25x)|20ml Adhesive plate sealers|4Materials required but not provided
- Microplate Reader capable of reading absorbance at 450nm.
- Incubator.
- Automated plate washer (optional).
- Pipettes and pipette tips capable of precisely dispensing 0.5 µl through 1 ml volumes of aqueous solutions.
- Multichannel pipettes are recommended for large amount of samples.
- Deionized or distilled water.
- 500ml graduated cylinders.
- Test tubes for dilution.
Activating reagent preparation
TGF beta 2 is mostly contained as inactive form in samples, please activate it before assay. Don't activate recombinant TGF beta 2.
Solution A: 1N HCI: add 8.33ml of 12N HCI into 91.67ml of H2O.
Solution B: 1.2N NaOH/0.5M HEPES: add 12ml of 10N NaOH and 11.9g HEPES into 75ml of H2O, add H2O to adjust volume to 100ml.
Sample activation procedure
Activate the sample
Cell culture supernatants: add activating reagent pro rata, i.e. add 20μl of Solution A into 100μl of sample, 10 min later, add 20μl of Solution B. PH 7.0-7.6.
Serum, plasma(heparin, EDTA or citrate): add activating reagent pro rata, i.e. add 20μl of Solution A into 40μl of sample, 10 min later, add 20μl of Solution B. PH 7.0-7.6.
It is unnecessary to activate the recombinant TGF-beta 2.
Sample was diluted partly after adding activating reagent, so please pay attention to this when calculate target protein concentration.
►How many samples can I run per plate?
►What sample dilution should I use?
►Why is my signal weak or absent?
►Why is my background signal high?
►Are the kit components sterile?
►How do I analyze my ELISA results?
►How should I store samples before running the assay?
►What positive and negative controls should I include?
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
- Yang et al. (2025). Laminarin-mediated oral delivery of miRNA-223 for targeted macrophage polarization in inflammatory bowel disease. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES.
- Chu et al. (2025). Protective effects of carboxymethyl chitosan-dialdehyde glucan/polydopamine carrier-delivered Bacillus subtilis on the i…. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES.
- Xianglei et al. (2025). Inhalable liposomal delivery of osimertinib and DNA for treating primary and metastasis lung cancer. Nature Communications.
- De et al. (2024). A novel oral vaccine delivery system for enhancing stability and immune protection: bacterium-like particle with functio…. Frontiers in Microbiology.
- He et al. (2024). A natural adhesive-based nanomedicine initiates photothermal-directed in situ immunotherapy with durability and maintena…. BIOMATERIALS.
- Gao et al. (2024). CCR7/DUSP1 signaling Axis mediates iCAF to regulates head and neck squamous cell carcinoma growth. CELLULAR SIGNALLING.
- Khan et al. (2024). Stat5b/Ezh2 axis governs high PD-L1 expressing tolerogenic dendritic cell subset in autoimmune diabetes. INTERNATIONAL IMMUNOPHARMACOLOGY.
- Jia et al. (2024). Proof of concept in utilizing the peptidoglycan skeleton of pathogenic bacteria as antigen delivery platform for enhance…. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES.
- Donghao et al. (2024). Mechanism of bufalin inhibition of colon cancer liver metastasis by regulating M2-type polarization of Kupffer cells ind…. APOPTOSIS.
- Hu et al. (2024). Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extra…. Journal for ImmunoTherapy of Cancer.
- Yuting et al. (2023). Long non-coding RNA ENSMUST00000197208 promotes a shift in the Th17/Treg ratio via the P2X7R-NLRP3 inflammasome axis in …. IMMUNOLOGIC RESEARCH.
- Ting et al. (2023). Efficient intervention for pulmonary fibrosis via mitochondrial transfer promoted by mitochondrial biogenesis. Nature Communications.
- Etebar et al. (2023). The immunomodulatory effects of the C-type lectin protein of Toxocara canis on experimental autoimmune encephalomyelitis. PARASITE IMMUNOLOGY.
- Tu et al. (2023). Anti-tumor effect of Crocus sativus petals polysaccharides by reconstructing tumor microenvironment. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES.
- Razliqi et al. (2023). Gentisic acid protects against diabetic nephropathy in Nicotinamide-Streptozotocin administered male mice by attenuating…. CHEMICO-BIOLOGICAL INTERACTIONS.
- Du et al. (2023). Combining Cryo-Thermal Therapy with Anti-IL-6 Treatment Promoted the Maturation of MDSCs to Induce Long-Term Survival in…. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.
- Dou et al. (2023). Orally Administrable H2S-Scavenging Metal–Organic Framework Prepared by Co-Flow Microfluidics for Comprehensive Restorat…. ADVANCED MATERIALS.
- Liu et al. (2022). Quercetin-Coating Promotes Osteogenic Differentiation, Osseointegration and Anti-Inflammatory Properties of Nano-Topogra…. Frontiers in Bioengineering and Biotechnology.
- Zhang et al. (2022). Neutrophil extracellular traps mediate m6A modification and regulates sepsis-associated acute lung injury by activating …. International Journal of Biological Sciences.
- Xue et al. (2022). Translocator protein (18 kDa) regulates the microglial phenotype in Parkinson’s disease through P47. Bioengineered.
- Hou et al. (2022). LIFU-responsive nanomedicine enables acoustic droplet vaporization-induced apoptosis of macrophages for stabilizing vuln…. Bioactive Materials.
- Wankun et al. (2022). Long Noncoding RNA HOTAIRM1 Promotes Immunosuppression in Sepsis by Inducing T Cell Exhaustion. JOURNAL OF IMMUNOLOGY.
- Xi et al. (2021). Vitamin D3 combined with antibody agents suppresses alloreactive memory T-cell responses to induce heart allograft long-…. TRANSPLANT IMMUNOLOGY.
- Wu et al. (2025). Glycyrrhizic acid-based nanotheranostic system to enhance photothermal immunotherapy by suppressing HSP90 and remodeling…. Materials Today Bio.
- (2025). Glycyrrhizic acid-based nanotheranostic system to enhance photothermal immunotherapy by suppressing HSP90 and remodeling….
- (2025). A novel strategy for activating glutathione S-transferases reveals the effects of HuaiHua San on CPT-11 induced diarrhea….
- (2025). Gut microbiota dysbiosis impairs TGF-β/Smad4 signaling to drive postoperative metastasis in colorectal cancer.